CAS 361440-67-7 Bohloeki >98.5% (HPLC) Feme
Ruifu Chemical Supply Related Intermediates
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Lebitso la Lik'hemik'hale | (1S,3S,5S) -3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester |
Litlhaloso tse tšoanang | N-Boc-L-cis-4,5-Methanoprolineamide;N-Boc-cis-4,5-Methano-L-Prolinamide;tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-Azabicyclo[3.1.0]hexane-2-Carboxylate |
Nomoro ea CAS | 361440-67-7 |
Nomoro ea KAtse | RF-PI1990 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C11H18N2O3 |
Boima ba Molek'hule | 226.27 |
Ntlha e belang | 388.9±21.0℃ |
Botenya | 1.228 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tshweu |
Mokhoa oa Bohloeki / Analysis | >98.5% (HPLC) |
Tahlehelo ka ho Omisa | <0.50% |
Masalla a ho Ignition | <0.20% |
Litšila tsa Motho ka Mong | <1.00% |
Litšila ka Kakaretso | <1.50% |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | Bohareng ba API (CAS: 361442-04-8) |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
(1S,3S,5S) -3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester (CAS: 361440-67-7) ke bohareng ba API (CAS: 361442 -04-8).(CAS: 361442-04-8) ke hypoglycemic ea molomo (anti-diabetic drug) ea sehlopha sa dipeptidyl peptidase-4 (DPP-4) inhibitor ea lithethefatsi.Tsoelo-pele ea pele e ne e le Bristol-Myers Squibb feela;ka 2007 AstraZeneca e ile ea ikopanya le Bristol-Myers Squibb ho kopanya motsoako oa ho qetela le ho sebelisana 'moho le papatso ea lithethefatsi.Ka June 2008, ho ile ha phatlalatsoa hore Onglyza e tla ba lebitso la khoebo leo ho tla rekisoa tlas'a lona.API (CAS: 361442-04-8) e sebelisoa e le monotherapy kapa hammoho le lithethefatsi tse ling bakeng sa kalafo ea lefu la tsoekere la mofuta oa 2.E kenella ka potlako kamora ho tsamaisoa ka molomo mme e na le profil ea pharmacokinetic e tsamaellanang le dosing hang ka letsatsi.E bapala karolo ka ho thibela ho senyeha ha GLP-l.GLP-I ke lihomone tsa tlhaho tse hlahisoang ka maleng ka mor'a ho ja.